Structure of the human protein kinase ZAK in complex with vemurafenib.
The mixed lineage kinase ZAK is a key regulator of the MAPK pathway mediating cell survival and inflammatory response. ZAK is targeted by several clinically approved kinase inhibitors, and inhibition of ZAK has been reported to protect fromdoxorubicin-induced cardiomyopathy. On the other hand, unint...
Prif Awduron: | Mathea, S, Abdul Azeez, K, Salah, E, Tallant, C, Wolfreys, F, Konietzny, R, Fischer, R, Lou, H, Brennan, P, Schnapp, G, Pautsch, A, Kessler, B, Turk, B, Knapp, S |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
American Chemical Society
2016
|
Eitemau Tebyg
-
Conformational plasticity of the ULK3 kinase domain
gan: Mathea, S, et al.
Cyhoeddwyd: (2021) -
Computational and Functional Analysis of Structural Features in the ZAKα Kinase
gan: Valdemar Brimnes Ingemann Johansen, et al.
Cyhoeddwyd: (2023-03-01) -
High-throughput purification of protein kinases from Escherichia coli and insect cells
gan: Mathea, S, et al.
Cyhoeddwyd: (2019) -
In Silico Studies of Novel Vemurafenib Derivatives as BRAF Kinase Inhibitors
gan: Teresa Żołek, et al.
Cyhoeddwyd: (2023-07-01) -
LA TRANSFORMADA DE ZAK
gan: Luis Miguel Nuñez Ramirez, et al.
Cyhoeddwyd: (2014-09-01)